India waives large-scale clinical trials for Sanofi’s dengue vaccine

An expert consultative committee of the Indian drug regulatory agency has waived a large-scale clinical trial for a dengue vaccine developed by Sanofi Pasteur. The Subject Expert Committee (SEC), which advises the Drug Controller General of India, said it recommends for market authorisation of the vaccine in the age group of 18-45 years only with …

India waives large-scale clinical trials for Sanofi’s dengue vaccine Read More »